New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
09:58 EDTARRYArray BioPharma sees Q3 EPS (14c), consensus (15c)
Sees Q3 revenue $14M, consensus $14.88M. Guidance from slides for Q2 earnings conference call.
News For ARRY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 4, 2015
13:17 EDTARRYOn The Fly: Top stock stories at midday
Stocks on Wall Street were higher at midday after having opened in positive territory and showing little movement in the early half of the day. ECONOMIC EVENTS: In the U.S., factory orders climbed 2.1% in March, which was roughly in-line with expectations. The New York ISM current business conditions index jumped to 58.1 in April from a prior reading of 50. In China, the final Purchasing Managers’ Index from HSBC and Markit for April came in at 48.9, which was below the preliminary reading of 49.2 and missed the consensus forecast of 49.4. In Europe, Markit's purchasing managers index for the eurozone’s manufacturing sector fell to 52.0 in April from 52.2 in March. COMPANY NEWS: Dow Chemical (DOW) announced it will cut approximately 1,500-1,750 positions, or approximately 3% of its global workforce, as part of streamlining the organization ahead of the company’s pending separation of a significant portion of its chlorine value chain... McDonald's shares declined fractionally after the company revealed details about the initial steps of the company's turnaround plan. The company said it will restructure its business into four new segments, accelerate the pace of its refranchising and reach the top end of its 3-year $18B-$20B cash return to shareholders target by the end of 2016... Cisco (CSCO) announced that Chuck Robbins will take over as CEO and that John Chambers will assume the role of executive chairman on July 26... Disney (DIS) moved up its second quarter earnings release and conference call following the sudden death of David Goldberg, the CEO of SurveyMonkey and husband of Facebook (FB) COO and Disney Board member Sheryl Sandberg. MAJOR MOVERS: Among the notable gainers was Array BioPharma (ARRY), which rose more than 15% after the company reported on its quarterly results and provided pipeline updates for binimetinib and encorafenib. Also higher after its earnings report was BroadSoft (BSFT), which gained almost 15%. Among the noteworthy losers was Spark Therapeutics (ONCE), which fell 4% after the New England Journal of Medicine published a study that found gene therapy created by another company that previously helped restore sight in patients with a rare form of childhood blindness peaked one to three years after treatment and had diminished by six years. Also lower were shares of Pioneer Natural Resources (PXD), which were down about 3% in afternoon trading after David Einhorn of Greenlight Capital spoke cautiously about the company and the fracking space in general while presenting at the Ira Sohn investor conference. INDEXES: Near midday, the Dow was up 64.48, or 0.36%, to 18,088.54, the Nasdaq was up 19.74, or 0.39%, to 5,025.13, and the S&P 500 was up 7.62, or 0.36%, to 2,115.91.
09:19 EDTARRYOn The Fly: Pre-market Movers
Subscribe for More Information
07:15 EDTARRYArray BioPharma provides pipeline updates for Binimetinib and Encorafenib
Subscribe for More Information
07:14 EDTARRYArray BioPharma reports Q3 EPS 37c, consensus (1c)
Subscribe for More Information
April 30, 2015
10:46 EDTARRYLeerink biotech analyst holds an analyst/industry conference call
Biotech Analyst Liang, along with Dr. Alan List an MDS Specialist, provide an update on the myelodysplastic syndrome pipeline on an Analyst/Industry conference call to be held on May 5 at 2:30 pm.
April 27, 2015
12:28 EDTARRYOptions with increasing implied volatility
Options with increasing implied volatility: THRX ARRY AKRX DECK HSBC
April 21, 2015
13:03 EDTARRYLoxo Oncology reports encouraging initial results from study for LOXO-101
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use